Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI Cancers (TREK)
TREK: Ketamine-assisted Psychotherapy (KAP) for Patients With Existential Distress Associated With Non-operable GI Cancers
Sponsor: University of Utah
Terminated
Challenges with feasibility
Other terminated trials from University of Utah
A EARLY_PHASE1 clinical study on Anxiety and Depression, this trial is terminated or withdrawn. The trial is conducted by University of Utah and has accumulated 7 data snapshots since 2023. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
May 2025 — Present [monthly]
Terminated EARLY_PHASE1
Status: Recruiting → Terminated
-
Sep 2024 — May 2025 [monthly]
Recruiting EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Recruiting EARLY_PHASE1
-
Apr 2024 — Jul 2024 [monthly]
Recruiting EARLY_PHASE1
-
Jan 2024 — Apr 2024 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
▶ Show 2 earlier versions
-
Nov 2023 — Jan 2024 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Sep 2023 — Nov 2023 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Utah
For direct contact, visit the study record on ClinicalTrials.gov .